Month: April 2024

Terranet AB (publ) or the (“Company”) today announces that the Company has received positive results from the previously communicated prototype tests performed in the lab during the first quarter. The data generated validates the technology and enables the company to initiate in-car tests in the near future and continue the development of BlincVision. During the tests, relevant measurements have been carried out on an ongoing basis in areas such as latency, object identification, object classification, light conditions and eye safety, which have been successfully carried out and have generated important data for continued product development. The main purpose was to validate the functionality and capacity of the system in a controlled environment. Particularly satisfying was verifying our unique and fast reaction time as well...

    Share Buyback Transaction Details March 28 – April 3, 2024 April 4, 2024 – Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 94,997 of its own ordinary shares in the period from March 28, 2024, up to and including April 3, 2024, for €13.6 million and at an average share price of €142.73. These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares for up to €1 billion during 2024. The cumulative amounts repurchased to date under this program are as follows: Share Buyback 2024Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2024 to date 1,903,728 270.6 142.16For the period starting February...

Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infectionsArboviruses are a growing emerging threat, with changes in climate and increasing global connectivity making the geographic spread more prevalentCE mark for Grifols’ Procleix ArboPlex Assay reinforces the company’s leadership in transfusion medicine and commitment to ensuring the safety of the world’s blood supplyBARCELONA, Spain, April 04, 2024 (GLOBE NEWSWIRE) — Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, today announced that its new Procleix ArboPlex Assay has obtained the CE mark under the In Vitro Diagnostic Regulation (IVDR), the first for an automated nucleic acid test (NAT) specifically...

Correction: Updated Annual Report attached April 4, 2024 Announcement no. 05 BioPorto Announces Annual Results for 2023 COPENHAGEN, DENMARK and BOSTON, MA, USA, April 4, 2024, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today financial results for the year ended December 31, 2023. Highlights 2023 Revenue and adjusted EBITDA in 2023 are in line with the preliminary results announced on February 22, 2024. Revenue amounted to DKK 31m (USD 4.5m), equivalent to a 7% increase over 2022, and the adjusted EBITDA loss amounted to DKK 56m (loss of USD 8.1m) As of December 31, 2023, the Company had cash and cash equivalents of DKK 66m (USD 9.8m). Outlook for 2024 As announced on February 22, 2024, the expected...

Investor news 4 April 2024 NKT invests in medium-voltage power cable business to boost capacity for growing demand To support growing demand from customers for medium-voltage power cables required for grid upgrades and renewable energy projects across Europe, NKT is investing in additional production capacity and capabilities at its medium-voltage factories in Denmark, Sweden and Czech Republic. The medium-voltage power cable market has grown steadily in recent years driven by the transition to renewable energy and the continued electrification of societies. Electrical grid operators are in the process of conducting major upgrade projects to keep apace. To satisfy this growing demand and maintain a strong position in the market, NKT is investing in additional medium-voltage capacity and capabilities. The investments are spread across...

The Hague, April 4, 2024 – Aegon Ltd. today published its Integrated Annual Report 2023. The report provides an overview of its businesses, the company’s strategy and sustainability approach, and its financial and non-financial performance. The report also reflects on the key trends that influence Aegon’s businesses and its stakeholders, and how these trends impact the way in which the company creates and shares value, today and in the future. You can find out more about Aegon’s purpose and other topics covered in the Integrated Annual Report 2023 here, and the report can be downloaded via Aegon.com. A hard copy of the report, including the audited financial statements, can be ordered free of charge by sending a request to our Investor Relations department. Aegon will also file its Annual Report 2023 on Form 20-F with the...

April 4, 2024 Announcement no. 05 BioPorto Announces Annual Results for 2023 COPENHAGEN, DENMARK and BOSTON, MA, USA, April 4, 2024, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today financial results for the year ended December 31, 2023. Highlights 2023 Revenue and adjusted EBITDA in 2023 are in line with the preliminary results announced on February 22, 2024. Revenue amounted to DKK 31m (USD 4.5m), equivalent to a 7% increase over 2022, and the adjusted EBITDA loss amounted to DKK 56m (loss of USD 8.1m) As of December 31, 2023, the Company had cash and cash equivalents of DKK 66m (USD 9.8m). Outlook for 2024 As announced on February 22, 2024, the expected revenue in 2024 is DKK 40m (USD 6m)...

Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the results of the Subsequent Acceptance Period following the voluntary reopening of TPG’s takeover Offer of Intervest. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de resultaten van de Bijkomende Aanvaardingsperiode na de vrijwillige heropening van het overnamebod van TPG op Intervest. Chère Madame, Cher Monsieur, Veuillez trouver ci-dessous les liens vers le récent communiqué de presse d’Intervest Offices & Warehouses concernant les résultats de la période d’acceptation subséquente suite à la réouverture volontaire de l’offre publique d’acquisition de TPG sur Intervest.AttachmentsENG_Intervest...

NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”)) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT. Azerion enters into an Intercreditor Agreement and a Super Senior Working Capital Facility Amsterdam, 4 April 2024 – Today, Azerion Group N.V. (the “Company”) announces it has entered into (i) an Intercreditor Agreement and (ii) a Super Senior Working Capital Facility Agreement with Citibank Europe plc (as original lender and agent), Citibank N.A., London Branch (as arranger) and Nordic Trustee & Agency AB (PUBL) (as security agent), amongst others, under which the Company is granted a EUR 15,000,000 super senior revolving credit...